Letairis / Volibris

At a Glance
Therapeutic Area:
Pulmonology
Approved Applications:
Letairis® (ambrisentan) is a prescription medicine to treat pulmonary arterial hypertension (PAH), which is high blood pressure in the arteries of your lungs. LETAIRIS® can improve your ability to exercise and it can help slow down the worsening of your physical condition and symptoms. PAH is a rare and fatal disorder of the arteries in the lungs which also affects the heart. It afflicts approximately 200,000 patients worldwide and can occur at any age.
Applications In Development:
N/A
Acquisition Date:
December 2009
Royalty Seller:


Latest News

  • No results
© 2014 Royalty Pharma, RP Management LLC. All Rights Reserved.